Pulmonary coccidioidomycosis

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Coccidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Clinical manifestations vary depending upon both the extent of infection and the immune status of the host. Coccidioidomycosis has been reported to involve almost all organ systems; however, pulmonary disease is the most common clinical manifestation. The incidence of coccidioidomycosis continues to rise, and primary coccidioidal pneumonia accounts for 17 to 29% of all cases of community-acquired pneumonia in endemic regions. The majority of patients with coccidioidomycosis resolve their initial infection without sequelae; however, several patients develop complications of disease ranging in severity from complicated pulmonary coccidioidomycosis to widely disseminated disease with immediately life-threatening manifestations. This review focuses on complications of pulmonary coccidioidomycosis with an emphasis on the management of primary coccidioidal infection, solitary pulmonary nodules, pleural effusions, cavitary disease, acute respiratory distress syndrome (ARDS), miliary disease, and sepsis.

Original languageEnglish (US)
Pages (from-to)754-763
Number of pages10
JournalSeminars in Respiratory and Critical Care Medicine
Volume32
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Coccidioidomycosis
Lung
Coccidioides
Pneumonia
Infection
Solitary Pulmonary Nodule
Adult Respiratory Distress Syndrome
Pleural Effusion
Lung Diseases
Sepsis
Fungi
Incidence

Keywords

  • amphotericin
  • Coccidioidomycosis
  • pulmonary
  • triazoles

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Pulmonary coccidioidomycosis. / Thompson, George Richard.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 32, No. 6, 2011, p. 754-763.

Research output: Contribution to journalArticle

@article{01bc795fe3d44b688d89564bddf079df,
title = "Pulmonary coccidioidomycosis",
abstract = "Coccidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Clinical manifestations vary depending upon both the extent of infection and the immune status of the host. Coccidioidomycosis has been reported to involve almost all organ systems; however, pulmonary disease is the most common clinical manifestation. The incidence of coccidioidomycosis continues to rise, and primary coccidioidal pneumonia accounts for 17 to 29{\%} of all cases of community-acquired pneumonia in endemic regions. The majority of patients with coccidioidomycosis resolve their initial infection without sequelae; however, several patients develop complications of disease ranging in severity from complicated pulmonary coccidioidomycosis to widely disseminated disease with immediately life-threatening manifestations. This review focuses on complications of pulmonary coccidioidomycosis with an emphasis on the management of primary coccidioidal infection, solitary pulmonary nodules, pleural effusions, cavitary disease, acute respiratory distress syndrome (ARDS), miliary disease, and sepsis.",
keywords = "amphotericin, Coccidioidomycosis, pulmonary, triazoles",
author = "Thompson, {George Richard}",
year = "2011",
doi = "10.1055/s-0031-1295723",
language = "English (US)",
volume = "32",
pages = "754--763",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Pulmonary coccidioidomycosis

AU - Thompson, George Richard

PY - 2011

Y1 - 2011

N2 - Coccidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Clinical manifestations vary depending upon both the extent of infection and the immune status of the host. Coccidioidomycosis has been reported to involve almost all organ systems; however, pulmonary disease is the most common clinical manifestation. The incidence of coccidioidomycosis continues to rise, and primary coccidioidal pneumonia accounts for 17 to 29% of all cases of community-acquired pneumonia in endemic regions. The majority of patients with coccidioidomycosis resolve their initial infection without sequelae; however, several patients develop complications of disease ranging in severity from complicated pulmonary coccidioidomycosis to widely disseminated disease with immediately life-threatening manifestations. This review focuses on complications of pulmonary coccidioidomycosis with an emphasis on the management of primary coccidioidal infection, solitary pulmonary nodules, pleural effusions, cavitary disease, acute respiratory distress syndrome (ARDS), miliary disease, and sepsis.

AB - Coccidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Clinical manifestations vary depending upon both the extent of infection and the immune status of the host. Coccidioidomycosis has been reported to involve almost all organ systems; however, pulmonary disease is the most common clinical manifestation. The incidence of coccidioidomycosis continues to rise, and primary coccidioidal pneumonia accounts for 17 to 29% of all cases of community-acquired pneumonia in endemic regions. The majority of patients with coccidioidomycosis resolve their initial infection without sequelae; however, several patients develop complications of disease ranging in severity from complicated pulmonary coccidioidomycosis to widely disseminated disease with immediately life-threatening manifestations. This review focuses on complications of pulmonary coccidioidomycosis with an emphasis on the management of primary coccidioidal infection, solitary pulmonary nodules, pleural effusions, cavitary disease, acute respiratory distress syndrome (ARDS), miliary disease, and sepsis.

KW - amphotericin

KW - Coccidioidomycosis

KW - pulmonary

KW - triazoles

UR - http://www.scopus.com/inward/record.url?scp=83655191211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655191211&partnerID=8YFLogxK

U2 - 10.1055/s-0031-1295723

DO - 10.1055/s-0031-1295723

M3 - Article

C2 - 22167403

AN - SCOPUS:83655191211

VL - 32

SP - 754

EP - 763

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 6

ER -